Skip to main content
Log in

Substantial cost of major adverse events in chronic CAD or PAD

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study was funded by Janssen, Titusville, NJ, US.

Reference

  • Berger A, et al. Incidence and Cost of Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients With Chronic Coronary Artery Disease or Peripheral Artery Disease. American Journal of Cardiology : 16 Mar 2019. Available from: URL: http://doi.org/10.1016/j.amjcard.2019.03.022

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Substantial cost of major adverse events in chronic CAD or PAD. PharmacoEcon Outcomes News 827, 32 (2019). https://doi.org/10.1007/s40274-019-5870-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5870-1

Navigation